Global coalition of investors urges action on antibiotic resistance ahead of UN meetings

Investor Statement – AMR 190916

19 September 2016

A global coalition of 75 stakeholders with $189 billion in assets under management is urging the private sector to take critical action to address antimicrobial resistance. Investors are asking companies to implement stricter policies on antibiotic use in livestock supply chains.

“We urge that the role of the animal health, food and agriculture industry is not overlooked and encourage the private sector to take critical action,” reads the investor statement.  

On Wednesday, the UN will host a High-Level Meeting on Antimicrobial Resistance at its headquarters in New York. The meeting will bring together Member States, non-governmental organisations, civil society, the private sector and academic institutions.

“[We] call on UN member states to bring clarity to antibiotic use recommendations currently in place through the implementation of stringent national and regional regulations, which will ensure that public health sits firmly at the heart of the food system,” the statement continues.

“As shareholders we urge animal health and food companies, including meat producers, restaurants and retailers, to end the use of antibiotics important to human medicine in their operations and global supply chains.” 

Investors include: Mirova; Strathclyde Pension Fund; Coller Capital; Menhaden Capital; and Trillium Asset Management.

Earlier this year, a coalition of investors worth over $1 trillion in assets wrote to 10 leading US and UK fast food and restaurant companies, to raise concerns about antimicrobial resistance. They asked the companies to phase out the routine use of medically important antibiotics in their meat and poultry supply chains. Investors are in continued dialogue with eight of the companies.

Notes for editors: